Medscape: First survival results with immunotherapy, TNBC
Rating: 5 Stars

Healeo: Atezolizumab prolongs OS for responders with triple-negative breast cancer
Rating: 4.5 Stars

MedPage Today: Response to PD-L1 drug boosts survival in TNBC
Rating: 4.0 Stars

TIME: Immunotherapy may treat this deadly breast cancer
Rating: 3 Stars